Table V.

Causes of death, by graft source and GVHD prophylaxis

	Bone marrow graft		Peripheral blood graft
	Conventional group (n = 25)	PTCy group (n = 15)	Conventional group (n = 17)	PTCy group (n = 4)
Disease recurrence/persistence	16 (64%)	5 (33.3%)	7 (41.2%)	–
Acute GVHD	–	3 (20%)	1 (5.9%)	2 (50%)
Chronic GVHD	1 (4%)	–	2 (11.7%)	2 (50%)
Graft failure/rejection	3 (12%)	1 (6.7%)	–	–
Infections	3 (12%)	4 (26.7%)	4 (23.5%)	–
Pneumonia	2 (8%)	–	–	–
Organ failure	–	1 (6.7%)	1 (5.9%)	–
Prior malignancy	–	–	1 (5.9%)	–
Other	–	1 (6.7%)	1 (5.9%)	–

GVHD, graft-versus-host disease; PTCy, Post-transplant cyclophosphamide.